Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
57.2M
-
Shares change
-
+10.2M
-
Total reported value, excl. options
-
$2.06B
-
Value change
-
+$356M
-
Put/Call ratio
-
1.72
-
Number of buys
-
98
-
Number of sells
-
-102
-
Price
-
$36.01
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q2 2021
273 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q2 2021.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.2M shares
of 98.7M outstanding shares and own 57.99% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.51M shares), VANGUARD GROUP INC (5.2M shares), MORGAN STANLEY (4.07M shares), Silver Lake Group, L.L.C. (3.53M shares), Atreides Management, LP (3.43M shares), GOLDMAN SACHS GROUP INC (2.81M shares), TIGER GLOBAL MANAGEMENT LLC (2.35M shares), FMR LLC (1.82M shares), Carmignac Gestion (1.78M shares), and Nuveen Asset Management, LLC (1.65M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.